Doximity vs Manhattan Associates
This page compares Doximity, Inc. and Manhattan Associates, Inc., highlighting business models, financial performance, and market context in a neutral, accessible manner. It presents objective information to help readers understand differences and similarities without guidance. Educational content, not financial advice.
This page compares Doximity, Inc. and Manhattan Associates, Inc., highlighting business models, financial performance, and market context in a neutral, accessible manner. It presents objective informa...
Investment Analysis
Doximity
DOCS
Pros
- Doximity has shown strong revenue growth of 19.98% in 2024, reaching approximately $570 million.
- The company benefits from robust profitability, with net income rising 51.23% to over $223 million in 2024.
- Doximity is innovating with expanded digital tools and AI-driven products, enhancing its healthcare communications platform.
Considerations
- Despite growth, Doximity’s stock appears overvalued by about 37%, with a high PE ratio above 58.
- Recent Q3 2025 revenue guidance disappointed, signaling potential near-term growth challenges.
- Increasing competition in digital healthcare communication may pressure market share and margins.
Pros
- Manhattan Associates is a leading provider of supply chain and warehouse management software, with strong industry positioning.
- The company has demonstrated steady revenue growth driven by increased demand for supply chain optimisation.
- Manhattan maintains an efficient business model with consistent profitability metrics and operating leverage.
Considerations
- The stock is sensitive to macroeconomic conditions affecting retail and logistics spending.
- Significant execution risks exist in integrating acquisitions and scaling complex software implementations.
- Valuation levels are elevated compared to historical averages, reflecting expectations of continued growth but limiting margin of safety.
Related Market Insights
No insights available in this category
Related Market Insights
No insights available in this category
Which Baskets Do They Appear In?
No baskets available in this category
Which Baskets Do They Appear In?
No baskets available in this category
Buy DOCS or MANH in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Doximity vs Skyworks
Doximity vs Skyworks compares business models, key financial metrics and market context to help readers understand each firm’s position, strengths and risks.
Doximity vs Procore
A neutral Doximity vs Procore comparison of business models, financials and market context to help readers research each stock, including risks and opportunity.
Doximity vs MACOM
A neutral Doximity vs MACOM stock comparison of business models, revenue drivers, profitability indicators, and market context to help readers research further.